Single-Use Bioprocessing Products Market Set to Reach USD 36 Billion by 2031 | Top Companies are Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corp.

The Global Single-Use Bioprocessing Products Market size was valued at USD 9200 million in 2022 and is estimated to reach USD 36000 million by 2031, growing at a CAGR of 18.6% during the forecast period (2024-2031).

According to DataM Intelligence has published a new research report on "Single-Use Bioprocessing Products Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Single-use bioprocessing products are disposable systems and components used in biopharmaceutical manufacturing to replace traditional stainless-steel equipment. These products include single-use bioreactors, bags, tubing, filters, connectors, and mixing systems, enabling faster setup, reduced contamination risk, lower cleaning validation costs, and greater manufacturing flexibility, especially in biologics, vaccines, cell & gene therapy, and monoclonal antibody production.

📌 Download Free Sample PDF:- https://datamintelligence.com/download-sample/single-use-bioprocessing-products-market?rk

➣ Recent Developments:

United States: Recent Industry Developments
✅ In July 2025, biopharma manufacturers expanded adoption of large-scale single-use bioreactors (≥2,000 L) to support commercial biologics production.
✅ In June 2025, suppliers introduced next-generation single-use filtration and fluid management systems to improve yield and process efficiency.
✅ In May 2025, increased investments were made in single-use solutions for cell and gene therapy manufacturing, supporting personalized medicine.

Europe: Recent Industry Developments
✅ In July 2025, European biomanufacturers accelerated the shift toward hybrid facilities combining single-use and stainless-steel systems.
✅ In June 2025, regulatory focus increased on extractables and leachables (E&L) testing for single-use components.
✅ In May 2025, demand grew for sustainable and recyclable single-use bioprocessing materials aligned with ESG goals.

Asia-Pacific: Recent Industry Developments
✅ In July 2025, China and South Korea expanded single-use biomanufacturing capacity for biosimilars and vaccines.
✅ In June 2025, India increased adoption of cost-efficient single-use systems to support contract manufacturing and exports.
✅ In May 2025, Japan advanced high-precision disposable bioprocessing assemblies for high-value biologics.

📌 Get Customization in the report as per your requirements: https://datamintelligence.com/customize/single-use-bioprocessing-products-market?rk

➣ Top Industry Players:

Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corp., Merck KGaA, Avantor, Inc., 3M, Eppendorf AG, Saint-Gobain Biopharm, Progenics Pharmaceuticals, Gore and more.

➣ Market Segments:

The market is segmented by product into single-use bioreactors (SUBs), tubing, connectors, clamps, disposable mixers, bags, containers, disposable filter cartridges, sampling systems, tangential flow filtration systems, membrane adsorbers, purification devices, preassembled tubing and rigging, and other related components. Single-use bioreactors and disposable fluid-handling systems are widely adopted due to their ability to reduce contamination risk, minimize cleaning requirements, and improve operational flexibility in bioprocessing workflows.

Based on application, the market is categorized into filtration, storage, cell culture, mixing, purification, and other uses. Cell culture and filtration applications account for a significant share, driven by the growing production of biologics, vaccines, and cell-based therapies that require efficient, scalable, and sterile processing solutions.

By end-user, the market includes biopharmaceutical manufacturers, life science R&D companies, academic research institutes, and others. Biopharmaceutical manufacturers dominate adoption due to large-scale biologics production, while research institutes and R&D organizations increasingly use single-use systems to support process development, clinical research, and pilot-scale manufacturing.

📌 Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=single-use-bioprocessing-products-market?rk

Regional Break out:

North America - 40%
North America holds the largest share of the global single-use bioprocessing products market due to the strong presence of biopharmaceutical manufacturers, advanced R&D infrastructure, and early adoption of disposable bioprocessing technologies. High biologics production, continuous investments in cell and gene therapy, and a mature regulatory ecosystem further support market dominance in this region.

Europe - 29%
Europe represents a significant portion of the market, driven by well-established pharmaceutical and biotechnology industries across countries such as Germany, the UK, France, and Switzerland. Increasing focus on cost-efficient manufacturing, sustainability, and regulatory compliance has accelerated the adoption of single-use systems across upstream and downstream bioprocessing operations.

Asia-Pacific - 23%
Asia-Pacific is the fastest-growing regional market, supported by expanding biologics manufacturing capacity, rising contract development and manufacturing organizations (CDMOs), and increased government funding for biotechnology in countries such as China, India, South Korea, and Japan. The region benefits from lower manufacturing costs and growing demand for vaccines and biosimilars.

Middle East & Africa - 8%
The Middle East & Africa market is in an emerging phase, with growth driven by increasing investments in healthcare infrastructure, local pharmaceutical manufacturing initiatives, and government efforts to improve biologics self-sufficiency. Adoption of single-use bioprocessing technologies is gradually increasing due to their flexibility and lower capital requirements.

South America - 5%
South America accounts for a smaller share of the global market, primarily driven by Brazil and Argentina. Growth is supported by expanding pharmaceutical manufacturing, rising demand for biologics, and gradual modernization of bioprocessing facilities, although market expansion is moderated by economic and regulatory challenges.

📌 Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/single-use-bioprocessing-products-market?rk

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?rk

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.